RICHMOND, British Columbia--(BUSINESS WIRE)--BioCurex, Inc. is pleased to announce a well-respected firm, TRI-STATE Capital (TSC), has upgraded their equity rating on BOCX. This strong upgrade comes at a time when the company released early results indicating a new form of cancer detection exposing more than twice the amount of cancers than most widely used cancer detection test utilized today --- the PSA test.
